Industry's highest-capacity discrete analyzer delivers true walk-away automation for commercial laboratories WESTBOROUGH, Mass. -- Commercial laboratories face mounting pressure to process more samples with fewer staff while maintaining fast turnaround times. When urgent samples arrive midday, labs face an impossible choice: disrupt current analyses to accommodate rush orders, or make clients wait. Meanwhile, technicians spend [...]

DKSH has signed an agreement to acquire Biomedic Science Material Joint Stock Company (“Biomedic”), a leading distributor of equipment and reagents used in the biotechnology and diagnostic market in Vietnam. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading [...]

Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation The Unveiling of M-Optimus: Bioptimus has trained its inaugural World Model for biology - a foundation model that learns interactions across multiple languages of biology - marking a revolutionary first step in simulating the full [...]

RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT® Direct RNA‑Seq (uMRT DRS) Kit, a native‑RNA library preparation solution for Oxford Nanopore Technologies® direct RNA sequencing (SQK-RNA004). The kit enables the detection of more genes, more isoforms, and longer transcripts than existing protocols. It [...]

BONADUZ, Switzerland -- Hamilton today announced the launch of GlucoSense, a breakthrough in bioprocess analytics that introduces the first reusable, in situ glucose sensor designed to deliver continuous, real-time measurements directly inside cell culture bioreactors. With this release, Hamilton is establishing an entirely new category of process sensors intended to make glucose control as routine and [...]

Non-exclusive license for Optimer® binder targeting the next-generation sequencing market Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce a first licensing agreement with Twist Bioscience, a leading synthetic biology and genomics company. Under the terms of the agreement, Aptamer has granted Twist Bioscience a non-exclusive [...]

New AI Models-as-a-Service offering to integrate in-silico design with experimental data to continuously improve predictive power and accelerate scientific innovation WALTHAM, Mass. --  Revvity, Inc. (NYSE: RVTY) today announced the introduction of its forthcoming Signals Xynthetica™ Models-as-a Service (MaaS) AI offering within the Revvity Signals platform. The Signals Xynthetica offering will enable AI-augmented molecular and materials design, and brings together [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new high-performance chromatography resins: AVIPure® HiPer™ AAV9 and AVIPure® HiPer™ AAV8 affinity resins, along with HiPer™ QA anion exchange resin, expanding the company’s growing proteins portfolio and reinforcing its commitment to innovation in next-generation bioprocessing. [...]

We launched the ChemiSphere app, a digital tool for scientists to instantly access product documentation and quality information via 2D barcodes. Connects physical products directly to digital workflows to reduce manual steps and boost efficiency Enables instant access to product documentation such as safety data sheets (SDS) and certificates of analysis (CoA) Built on the [...]

CAMBRIDGE, Ontario--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Doug Wright has been appointed Chief Executive Officer (CEO) and a member of its Board of Directors, commencing on or before January 14, 2026. Mr. Wright’s appointment follows a comprehensive search led by ATS’ Board of Directors. "We are very pleased [...]